Strong Effectiveness of NanoViricides Drug Candidates Observed in Animal Model using Human Coronavirus
| Date | 24th, May 2020 |
|---|---|
| Source | Technology Org - Scientific News Websites |
DESCRIPTION
NanoViricides, Inc. a leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, announced today that strong effectiveness against infection by an ACE2-utilizing coronavirus in an animal model has been observed for the drug candidates it is developing against SARS-CoV-2 to treat COVID-19 spectrum of diseases.